Policy

Building collaborative relationships to overcome challenges in the CGT industry 2:46
Building collaborative relationships to overcome challenges in the CGT industry
Sharon Brownlow • 26 Jan 2022
Achieving operational excellence in CGT through automation 4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow • 26 Jan 2022
Upscaling cell and gene therapy manufacturing 1:18
Upscaling cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
Increasing recruitment in the cell and gene therapy sector 5:07
Increasing recruitment in the cell and gene therapy sector
Sharon Brownlow • 26 Jan 2022
The need for standardization in cell and gene therapy manufacturing 2:14
The need for standardization in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
CMC challenges in cell and gene therapy manufacturing 1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
The ISCT’s ongoing battle against unproven cell & gene therapies 2:32
The ISCT’s ongoing battle against unproven cell & gene therapies
Miguel Forte • 5 Oct 2021
The challenges of CMC in cell and gene therapies 2:05
The challenges of CMC in cell and gene therapies
Mike Lehmicke • 17 Mar 2021
Supporting the future of ATMPs in the EU 2:21
Supporting the future of ATMPs in the EU
Paige Bischoff • 17 Mar 2021
A-Gene: a best practice guide for gene therapy development 1:13
A-Gene: a best practice guide for gene therapy development
Mike Lehmicke • 17 Mar 2021
CAR-T regulatory issues and reimbursements 0:49
CAR-T regulatory issues and reimbursements
Jürgen Kuball • 27 Jan 2021
The regulatory process for CAR-T in Europe: EBMT registry & GoCART 2:28
The regulatory process for CAR-T in Europe: EBMT registry & GoCART
Jürgen Kuball • 27 Jan 2021
Regulatory considerations for CAR-T academic trials 1:45
Regulatory considerations for CAR-T academic trials
Manel Juan Otero • 25 Jan 2021
Update on ARI-0001 for patients with CD19+ R/R malignancies 2:47
Update on ARI-0001 for patients with CD19+ R/R malignancies
Manel Juan Otero • 25 Jan 2021
Collaboration in the field of cellular therapies 1:48
Collaboration in the field of cellular therapies
Sofie Terwel • 28 Jan 2021
GoCART Coalition: collaboration across stakeholders 2:50
GoCART Coalition: collaboration across stakeholders
Sofie Terwel • 28 Jan 2021
The content of VJRegenMed is intended for healthcare professionals